133 related articles for article (PubMed ID: 11418153)
21. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
[TBL] [Abstract][Full Text] [Related]
22. Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer.
Kalfert D; Ludvikova M; Topolcan O; Windrichova J; Malirova E; Pesta M; Celakovsky P
Anticancer Res; 2014 Dec; 34(12):7431-41. PubMed ID: 25503184
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of soluble interleukin-2 receptor-alpha in adenocarcinoma of the pancreas.
Gansauge F; Steinbach G; Gansauge S; König HH; Müller J; Grünert A; Beger HG
Cancer Lett; 1998 Dec; 134(2):193-9. PubMed ID: 10025881
[TBL] [Abstract][Full Text] [Related]
25. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
Imai R; Takenaka Y; Yasui T; Nakahara S; Yamamoto Y; Hanamoto A; Takemoto N; Fukusumi T; Cho H; Yamamoto M; Inohara H
Acta Otolaryngol; 2015 Mar; 135(3):295-301. PubMed ID: 25622661
[TBL] [Abstract][Full Text] [Related]
27. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours.
Banal A; Hacene K; Berthelot-Ruff E; Mahé E; Fontana X; Pichon MF
Tumour Biol; 2001; 22(1):27-35. PubMed ID: 11054024
[TBL] [Abstract][Full Text] [Related]
33. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
Bien E; Balcerska A
Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
[TBL] [Abstract][Full Text] [Related]
34. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
[TBL] [Abstract][Full Text] [Related]
35. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of albumin in patients with head and neck cancer.
Danan D; Shonka DC; Selman Y; Chow Z; Smolkin ME; Jameson MJ
Laryngoscope; 2016 Jul; 126(7):1567-71. PubMed ID: 26864349
[TBL] [Abstract][Full Text] [Related]
37. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
39. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer.
Wu LJ; Chen KY; Chi KH; Chen SY; Liang MJ; Shiau CY; Wang LW; Liu YM; Chow KC; Yen SH
Jpn J Clin Oncol; 1998 Dec; 28(12):729-32. PubMed ID: 9879289
[TBL] [Abstract][Full Text] [Related]
40. Elevated arginine vasopressin levels in squamous cell cancer of the head and neck.
Talmi YP; Wolf GT; Hoffman HT; Krause CJ
Laryngoscope; 1996 Mar; 106(3 Pt 1):317-21. PubMed ID: 8614196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
